Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 5,506 | 6,445 | 8,067 | 7,751 | 6,012 |
| Cost of Goods | 3,143 | 3,627 | 4,713 | 4,920 | 4,428 |
| Gross Profit | 2,363 | 2,818 | 3,354 | 2,832 | 1,584 |
| Operating Expenses | 2,486 | 2,875 | 2,950 | 3,130 | 2,587 |
| Operating Income | 20 | 570 | 1,118 | 621 | -575 |
| Other Income | -155 | -66 | 331 | -101 | -126 |
| Pre-tax Income | -135 | 504 | 1,449 | 521 | -700 |
| Income Tax | 5 | 2 | 2 | 6 | 1 |
| Net Income Continuous | -140 | 502 | 1,447 | 515 | -702 |
| Net Income | $-140 | $502 | $1,447 | $515 | $-702 |
| EPS Basic Total Ops | -0.02 | 0.06 | 0.16 | 0.09 | -0.09 |
| EPS Basic Continuous Ops | -0.02 | 0.06 | 0.16 | 0.07 | -0.09 |
| EPS Diluted Total Ops | -0.02 | 0.06 | 0.16 | 0.09 | -0.09 |
| EPS Diluted Continuous Ops | -0.02 | 0.06 | 0.16 | 0.07 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.02 | 0.06 | 0.16 | 0.06 | -0.09 |
| EBITDA(a) | $729 | $1,249 | $1,804 | $1,306 | $111 |